Suppr超能文献

RIOK2 促进人口腔鳞状细胞癌细胞的生长和蛋白质合成。

RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma.

机构信息

Department of Bioregulation, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo 113-8602, Japan.

Department of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo 101-0061, Japan.

出版信息

Curr Oncol. 2022 Dec 26;30(1):381-391. doi: 10.3390/curroncol30010031.

Abstract

Ribosomes are responsible for the protein synthesis that maintains cellular homeostasis and is required for the rapid cellular division of cancer cells. However, the role of ribosome biogenesis mediators in the malignant behavior of tongue squamous cell carcinoma (TSCC) is unknown. In this study, we found that the expression of RIOK2, a key enzyme involved in the maturation steps of the pre-40S ribosomal complex, was significantly associated with poorer overall survival in patients with TSCC. Further, multivariate analysis revealed that RIOK2 is an independent prognostic factor (hazard ratio, 3.53; 95% confidence interval, 1.19-10.91). Inhibition of RIOK2 expression by siRNA decreased cell growth and S6 ribosomal protein expression in oral squamous cell carcinoma cell lines. RIOK2 knockdown also led to a significant decrease in the protein synthesis in cancer cells. RIOK2 has potential application as a novel therapeutic target for TSCC treatment.

摘要

核糖体负责维持细胞内稳态的蛋白质合成,是癌细胞快速分裂所必需的。然而,核糖体生物发生介质在舌鳞状细胞癌 (TSCC) 的恶性行为中的作用尚不清楚。在这项研究中,我们发现,参与 pre-40S 核糖体复合物成熟步骤的关键酶 RIOK2 的表达与 TSCC 患者的总生存率显著相关。此外,多变量分析显示 RIOK2 是一个独立的预后因素(风险比,3.53;95%置信区间,1.19-10.91)。用 siRNA 抑制 RIOK2 的表达可降低口腔鳞状细胞癌细胞系中的细胞生长和 S6 核糖体蛋白表达。RIOK2 敲低也导致癌细胞中的蛋白质合成显著减少。RIOK2 有望成为治疗 TSCC 的一种新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011a/9857684/872c56bfa36e/curroncol-30-00031-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验